UBS Group’s Avadel Pharmaceuticals AVDL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$7.75M Sell
875,239
-419,393
-32% -$3.71M ﹤0.01% 2665
2025
Q1
$10.1M Sell
1,294,632
-276,228
-18% -$2.16M ﹤0.01% 2346
2024
Q4
$16.5M Buy
1,570,860
+963,556
+159% +$10.1M ﹤0.01% 1921
2024
Q3
$7.96M Buy
607,304
+372,962
+159% +$4.89M ﹤0.01% 1865
2024
Q2
$3.29M Buy
234,342
+220,812
+1,632% +$3.1M ﹤0.01% 2436
2024
Q1
$229K Buy
13,530
+2,230
+20% +$37.7K ﹤0.01% 4624
2023
Q4
$160K Sell
11,300
-134
-1% -$1.89K ﹤0.01% 4726
2023
Q3
$118K Sell
11,434
-1,954
-15% -$20.1K ﹤0.01% 4617
2023
Q2
$221K Buy
13,388
+2,717
+25% +$44.8K ﹤0.01% 4384
2023
Q1
$97.7K Buy
10,671
+7,745
+265% +$70.9K ﹤0.01% 4860
2022
Q4
$21K Sell
2,926
-9,029
-76% -$64.6K ﹤0.01% 6422
2022
Q3
$60K Buy
11,955
+8,971
+301% +$45K ﹤0.01% 5098
2022
Q2
$7K Sell
2,984
-323
-10% -$758 ﹤0.01% 7408
2022
Q1
$23K Sell
3,307
-4,951
-60% -$34.4K ﹤0.01% 6238
2021
Q4
$67K Sell
8,258
-4,243
-34% -$34.4K ﹤0.01% 5567
2021
Q3
$122K Sell
12,501
-983
-7% -$9.59K ﹤0.01% 4619
2021
Q2
$91K Buy
13,484
+6,616
+96% +$44.7K ﹤0.01% 4916
2021
Q1
$63K Buy
6,868
+2,160
+46% +$19.8K ﹤0.01% 5324
2020
Q4
$32K Buy
4,708
+733
+18% +$4.98K ﹤0.01% 5566
2020
Q3
$20K Sell
3,975
-719
-15% -$3.62K ﹤0.01% 5431
2020
Q2
$38K Buy
4,694
+1,469
+46% +$11.9K ﹤0.01% 5251
2020
Q1
$26K Sell
3,225
-3,995
-55% -$32.2K ﹤0.01% 5419
2019
Q4
$54K Buy
7,220
+2,770
+62% +$20.7K ﹤0.01% 5261
2019
Q3
$18K Buy
4,450
+2,444
+122% +$9.89K ﹤0.01% 5829
2019
Q2
$6K Buy
2,006
+1,902
+1,829% +$5.69K ﹤0.01% 6421
2019
Q1
$0 Sell
104
-3,075
-97% ﹤0.01% 6853
2018
Q4
$8K Sell
3,179
-2,838
-47% -$7.14K ﹤0.01% 6407
2018
Q3
$26K Buy
6,017
+1,321
+28% +$5.71K ﹤0.01% 5719
2018
Q2
$29K Buy
4,696
+3,487
+288% +$21.5K ﹤0.01% 5490
2018
Q1
$8K Sell
1,209
-740
-38% -$4.9K ﹤0.01% 6104
2017
Q4
$16K Buy
1,949
+1,895
+3,509% +$15.6K ﹤0.01% 5746
2017
Q3
$1K Sell
54
-2,438
-98% -$45.1K ﹤0.01% 6628
2017
Q2
$28K Buy
2,492
+2,362
+1,817% +$26.5K ﹤0.01% 5117
2017
Q1
$2K Sell
130
-3,185
-96% -$49K ﹤0.01% 6337
2016
Q4
$35K Buy
3,315
+1,459
+79% +$15.4K ﹤0.01% 5181
2016
Q3
$23K Sell
1,856
-1,661
-47% -$20.6K ﹤0.01% 5295
2016
Q2
$38K Buy
3,517
+1,731
+97% +$18.7K ﹤0.01% 4871
2016
Q1
$19K Buy
1,786
+1,750
+4,861% +$18.6K ﹤0.01% 5398
2015
Q4
$0 Sell
36
-720
-95% ﹤0.01% 6851
2015
Q3
$12K Sell
756
-43,138
-98% -$685K ﹤0.01% 5806
2015
Q2
$930K Buy
43,894
+9,742
+29% +$206K ﹤0.01% 2854
2015
Q1
$614K Sell
34,152
-10,022
-23% -$180K ﹤0.01% 3084
2014
Q4
$757K Buy
+44,174
New +$757K ﹤0.01% 2900